Gloria Sakwari1, Simon H D Mamuya, Magne Bråtveit, Bente E Moen. 1. Department of Public Health and Primary Health Care and Centre for International Health, University of Bergen, Bergen, Hordaland, Norway. gsakwari@yahoo.com
Abstract
OBJECTIVE: To compare chronic respiratory symptoms, fractional exhaled nitric oxide (FENO), and lung function between Robusta and Arabica coffee workers and a control group. METHODS: Chronic respiratory symptoms were assessed by a questionnaire (n = 138 coffee workers and n = 120 controls). The FENO was measured by NIOX MINO device (Aerocrine AB, Solna, Sweden). Lung function was examined by a portable spirometer. RESULTS: Coffee workers had higher prevalence of chronic respiratory and asthma symptoms than controls. Robusta coffee workers were exposed to higher levels of endotoxin and had more asthma symptoms than Arabica coffee workers (38% vs. 18%). Coffee workers had reduced lung function associated with cumulative exposure to total dust and endotoxin. CONCLUSION: Work in coffee factories is associated with small but significant lung function impairment. These changes were not associated with the level of FENO.
OBJECTIVE: To compare chronic respiratory symptoms, fractional exhaled nitric oxide (FENO), and lung function between Robusta and Arabica coffee workers and a control group. METHODS: Chronic respiratory symptoms were assessed by a questionnaire (n = 138 coffee workers and n = 120 controls). The FENO was measured by NIOX MINO device (Aerocrine AB, Solna, Sweden). Lung function was examined by a portable spirometer. RESULTS: Coffee workers had higher prevalence of chronic respiratory and asthma symptoms than controls. Robusta coffee workers were exposed to higher levels of endotoxin and had more asthma symptoms than Arabica coffee workers (38% vs. 18%). Coffee workers had reduced lung function associated with cumulative exposure to total dust and endotoxin. CONCLUSION: Work in coffee factories is associated with small but significant lung function impairment. These changes were not associated with the level of FENO.
Authors: Nicholas G Davey; Larissa C Richards; Jonathan Davidson; Trevor Michalchuk; Christopher G Gill; Erik T Krogh; Christopher D Simpson Journal: Ann Work Expo Health Date: 2022-06-06 Impact factor: 2.779
Authors: Bente Elisabeth Moen; Akwilina Kayumba; Gloria Sakwari; Simon Henry David Mamuya; Magne Bråtveit Journal: J Occup Med Toxicol Date: 2016-04-12 Impact factor: 2.646
Authors: Samson Wakuma Abaya; Magne Bråtveit; Wakgari Deressa; Abera Kumie; Bente E Moen Journal: Int J Environ Res Public Health Date: 2018-10-31 Impact factor: 3.390
Authors: R Reid Harvey; Ethan D Fechter-Leggett; Rachel L Bailey; Nicole T Edwards; Kathleen B Fedan; M Abbas Virji; Randall J Nett; Jean M Cox-Ganser; Kristin J Cummings Journal: Front Public Health Date: 2020-01-30